Public Company News

Massimo Group Reports Strong Pre-Order Demand for Sentinel Series HVAC UTVs Following AIMExpo 2026

GARLAND, Texas, Jan. 20, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and electric utility solutions, today reported robust pre-order activity for its 2026 Sentinel Series fully enclosed HVAC utility terrain vehicles (UTVs) following it...

2026-01-20 22:00 8027

NYSE Content Advisory: Pre-Market Update + NYSE Creates Tokenized Securities Platform for 24/7 Trading

NEW YORK, Jan. 20, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + NYSE Creates Tokenize...

2026-01-20 21:55 9253

Netflix and Warner Bros. Discovery Amend Agreement to All-Cash Transaction

All-Cash Structure Increases Value Certainty for WBD Stockholders, Accelerates WBD Stockholder Vote and Underscores Netflix's Financial Strength WBD Files Preliminary Proxy Statement for Transaction Approval HOLLYWOOD, Calif. and NEW YORK, Jan. 20, 2026 /PRNewswire/ -- Netflix, Inc. (NASDAQ:NFLX...

2026-01-20 20:24 8463

LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders

BEIJING, Jan. 20, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics f...

2026-01-20 20:00 9798

4DMedical Secures US$100+ Million Funding to Accelerate U.S. Expansion and increase Technology Dominance in Software-Based Lung Imaging

Funding will scale hospital deployments for groundbreaking CT:VQ™ imaging product,strongly advance R&D, support early adopters at Stanford, Cleveland Clinic, University of Miami, UC San Diego Health, and more LOS ANGELES and MELBOURNE, Australia, Jan. 20, 2026 /PRNewswire/ -- 4DMedical, the lead...

2026-01-20 19:00 8222

Solidion Technology Awarded Its Third Grant From The U.S. Army STTR Program

Grant Proceeds Will Accelerate Research Into Advanced Fiber-based Electronic Battery Systems DALLAS, Jan. 20, 2026 /PRNewswire/ -- Solidion Technology Inc. ("Solidion" or the "Company") (Nasdaq: STI), an advanced battery technology solutions provider, was notified by the U.S. Department of War/A...

2026-01-20 19:00 5690

Noah Holdings' H1 2026 CIO Report Outlines the Emergence of AI Infrastructure as a Critical Long-Term Asset for Wealth Allocation

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- Noah Holdings Limited ("Noah" or the "Company") (NYSE: NOAH and HKEX: 6686), an established wealth management service provider offering comprehensive one-stop advisory services on global investment and asset allocation primarily for global Chinese high-net...

2026-01-20 18:35 22154

ZTO Express Holds 2026 National Network Conference

SHANGHAI, Jan. 20, 2026 /PRNewswire/ -- On January 20, 2026, ZTO Express (Cayman) Inc. (NYSE: ZTO and SEHK: 2057) ("ZTO" or the "Company"), a leading and fast-growing express delivery enterprise in China, convened its National Network Conference at its headquarters in Shanghai. The conference con...

2026-01-20 18:00 10494

Building the Run: Xtep Charts a New Community Ecosystem in Southeast Asia

JAKARTA, Indonesia and KUALA LUMPUR, Malaysia, Jan. 20, 2026 /PRNewswire/ -- Global performance sportswear brand Xtep Group has inaugurated its 2026 Southeast Asia expansion with the debut of new, experience-driven hubs in Jakarta and Kuala Lumpur. More than mere retail openings, these launches ...

2026-01-20 17:49 20739

Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development

- In head-to-head non-human primate (NHP) studies, average observed half-life of ASC37 was approximately 17 days, 7-fold longer than retatrutide, which supports once-monthly subcutaneous (SQ) dosing in humans. - ASC37's average in vitro activity was approximately 5-, 4-, and 4-fold more potent t...

2026-01-20 17:00 7805

GIBO Advances Toward Integrated Autonomous Mobility Systems, Building a Unified AI Stack Across Air and Ground Platforms

KUALA LUMPUR, Malaysia, Jan. 20, 2026 /PRNewswire/ -- GIBO Holdings Ltd. (NASDAQ: GIBO),Asia's leading innovation-driven AI ecosystem, today announced the next evolution of its AI mobility roadmap, advancing theGIBO.ai Calculation Engine toward a unified, cross-domain intelligence stack supportin...

2026-01-20 17:00 9776

Infosys is the Fastest Growing IT Services Brand Globally with a CAGR of 15% in Brand Value

Top 3 Most Valuable IT Services Brand In the world. A Top 100 Brand across categories in Brand Strength DAVOS, Switzerland, Jan. 20, 2026 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consul...

2026-01-20 16:13 5169

Alteogen Announces Exclusive License Agreement with Tesaro, a Subsidiary of GSK, for the Development of a Subcutaneous Formulation of Dostarlimab Enabled by Hybrozyme™ Technology

DAEJEON, South Korea, Jan. 20, 2026 /PRNewswire/ -- Alteogen Inc. (KOSDAQ: 196170) announced today that the company has entered into an exclusive license agreement with Tesaro, Inc., a subsidiary of GSK. Under the terms of the agreement, Tesaro will acquire world-wide rights to use ALT-B4, Alteog...

2026-01-20 15:55 8278

Telix Achieves FY 2025 Guidance with US$804M (A$1.2B) Revenue, Accelerates Growth with Gozellix Launch

MELBOURNE, Australia and INDIANAPOLIS, Ind., Jan. 20, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides an update on its commercial and operational performance for the quarter ended 31 December 2025 (Q4 2025). Q4 2025 Highlights * Full-year (FY) 2...

2026-01-20 15:16 10999

CMES Robotics Expands AI-Driven Warehouse Automation Footprint with New Logistics Projects

How Innovative Companies Are Solving Palletizing and Depalletizing Challenges Across eCommerce, Logistics, Food & Beverage, and Manufacturing SEATTLE, Jan. 20, 2026 /PRNewswire/ -- CMES Robotics, a leading provider of advanced AI vision solutions, today announced it has secured additional automa...

2026-01-20 13:00 5529

Beauty Farm Issues Positive Profit Alert for 2025

HONG KONG, Jan. 20, 2026 /PRNewswire/ -- Beauty Farm Medical and Health Industry Inc. ("Beauty Farm" or the "Company") (02373.HK), one of the largest beauty and wellness services providers in China,issued a positive profit alert for the year ended December 31, 2025. As disclosed, the Company ant...

2026-01-20 12:14 9028

6Letters Launches "MOJO KING," an Apple Watch-Based iOS App for Non-Invasive Testosterone Monitoring

SEOUL, South Korea, Jan. 19, 2026 /PRNewswire/ -- Digital healthcare startup  6Letters today announced the official launch of MOJO KING, an iOS application that enables non-invasive monitoring of testosterone-related physiological patterns using Apple Watch data.

2026-01-20 10:19 6675

NEC Wins Five Awards at Newsweek AI Impact APAC & EMEA Awards

- How NEC's AI Is Creating What's Ahead in Vietnam - TOKYO, Jan. 20, 2026 /PRNewswire/ -- NEC Corporation  (NEC; TSE: 6701) recently won awards in five categories at the Newsweek AI Impact APAC & EMEA Awards, which identify and recognize organizations for their inn...

2026-01-20 10:00 9442

CSOP CSAM CSI A500 Index ETF Lists on Singapore Exchange Today

SINGAPORE, Jan. 20, 2026 /PRNewswire/ -- Singapore's first CSI A500 Index ETF—CSOP CSAM CSI A500 Index ETF (Stock Code: SUN), lists on Singapore Exchange (SGX) today (January 20, 2026). SUN's listing price is SGD 1 per share, with a trading lot size of 1 share and an annual management fee of 0.89...

2026-01-20 09:00 8174

AIM Vaccine's 20-Valent Pneumococcal Conjugate Vaccine Receives Clinical Approval, Upgraded Iterative Major Product Expected to Seize Domestic Opportunities

HONG KONG, Jan. 20, 2026 /PRNewswire/ -- AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 19 that it has developed an optimized upgraded version of its iterative 20-valent pneumococcal conjugate vaccine, which has recently received clinical trial approval from the ...

2026-01-20 08:23 6050